pipeline  cytokinetics our focus we’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions overview how muscles work amyotrophic lateral sclerosis heart failure spinal muscular atrophy pipeline we’re advancing muscle biologydriven treatments for diseases characterized by compromised muscle function muscle weakness and fatigue overview omecamtiv mecarbil tirasemtiv ck publications scientific events clinical trials we have conducted more than  clinical trials as we strive to bring important new medicines to patients with diseases like als heart failure and sma overview helpful resources expanded accesscompassionate use company cytokinetics is a latestage biopharmaceutical company focused on discovering developing and commercializing firstinclass muscle activators overview leadership team careers our culture grant programs contact us investors  media cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance investor overview stock information press releases in the news calendar presentations sec filings proxy information analyst coverage investor faq irmedia contacts corporate governance information request email alerts a pipeline powered bypassion shareprint pipeline preclinical phase  phase  phase  skeletal muscle tirasemtiv als astellas option ck sma astellas collaboration ck copd astellas collaboration ck frailty astellas collaboration ck astellas collaboration cardiac muscle omecamtiv mecarbil heart failure amgen collaboration research next generation cardiac muscle activators amgen collaboration next generation skeletal muscle activators astellas collaboration other muscle biology directed research type indication phase skeletal muscle tirasemtiv als ck sma ck copd ck frailty ck     preclinical cardiac muscle omecamtiv mecarbil heart failure  research next generation cardiac muscle activators next generation skeletal muscle activators other muscle biology directed research preclinical preclinical preclinical outside north america  europe omecamtiv mecarbil in collaboration with amgen we are developing a novel therapy that may improve cardiac performance in patients with heart failure tirasemtiv we’re focused on providing a new treatment option for people living with als a progressive degenerative neuromuscular disease that affects movement and breathing ck with astellas ck is being developed as a potential treatment of sma a genetic disease affecting motor neurons in the spinal cord and the control of muscle movement publications we’re proud to be a leader in muscle biology and of our history of innovative scientific research read more about our work to develop medicines for people suffering from diseases that rob them of key muscle functions scientific events the cytokinetics team attends scientific events throughout the year learn more about where we will be discussing our research and clinical programs cytokinetics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports cytokinetics inc  product pipeline review   cytokinetics inc  product pipeline review   wgr  may  global  pages global markets direct description table of content sample report enquiry before buy related reports cytokinetics inc  product pipeline review  summaryglobal markets direct’s ‘cytokinetics inc  product pipeline review  ’ provides an overview of the cytokinetics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of cytokinetics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the cytokinetics inc’s pipeline productsreasons to buy evaluate cytokinetics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of cytokinetics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the cytokinetics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures cytokinetics inc snapshot cytokinetics inc overview key information key facts cytokinetics inc  research and development overview key therapeutic areas cytokinetics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities cytokinetics inc  pipeline products glance cytokinetics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities cytokinetics inc  early stage pipeline products preclinical productscombination treatment modalities cytokinetics inc  drug profiles tirasemtiv product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress small molecule to inhibit myosin for copd asthma and pulmonary arterial hypertension product description mechanism of action rd progress small molecules for cardiovascular diseases product description mechanism of action rd progress cytokinetics inc  pipeline analysis cytokinetics inc  pipeline products by target cytokinetics inc  pipeline products by route of administration cytokinetics inc  pipeline products by molecule type cytokinetics inc  pipeline products by mechanism of action cytokinetics inc  recent pipeline updates cytokinetics inc  dormant projects cytokinetics inc  company statement cytokinetics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablescytokinetics inc key information cytokinetics inc key facts cytokinetics inc  pipeline by indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  outlicensed products combination treatment modalities  cytokinetics inc  phase ii  cytokinetics inc  phase i  cytokinetics inc  preclinical  cytokinetics inc  pipeline by target  cytokinetics inc  pipeline by route of administration  cytokinetics inc  pipeline by molecule type  cytokinetics inc  pipeline products by mechanism of action  cytokinetics inc  recent pipeline updates  cytokinetics inc  dormant developmental projects list of figurescytokinetics inc  pipeline by top  indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  pipeline by top  target  cytokinetics inc  pipeline by top  route of administration  cytokinetics inc  pipeline by top  molecule type  cytokinetics inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send cytokinetics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report cytokinetics inc  product pipeline review   published by global markets direct product code  published may   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license cytokinetics inc  product pipeline review   published may   content info  pages description summary global markets directs cytokinetics inc  product pipeline review   provides an overview of the cytokinetics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of cytokinetics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the cytokinetics incs pipeline products reasons to buy evaluate cytokinetics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of cytokinetics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the cytokinetics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures cytokinetics inc snapshot cytokinetics inc overview key information key facts cytokinetics inc  research and development overview key therapeutic areas cytokinetics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities cytokinetics inc  pipeline products glance cytokinetics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities cytokinetics inc  early stage pipeline products preclinical productscombination treatment modalities cytokinetics inc  drug profiles tirasemtiv product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress small molecule to inhibit myosin for copd asthma and pulmonary arterial hypertension product description mechanism of action rd progress small molecules for cardiovascular diseases product description mechanism of action rd progress cytokinetics inc  pipeline analysis cytokinetics inc  pipeline products by target cytokinetics inc  pipeline products by route of administration cytokinetics inc  pipeline products by molecule type cytokinetics inc  pipeline products by mechanism of action cytokinetics inc  recent pipeline updates cytokinetics inc  dormant projects cytokinetics inc  company statement cytokinetics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables cytokinetics inc key information cytokinetics inc key facts cytokinetics inc  pipeline by indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  outlicensed products combination treatment modalities  cytokinetics inc  phase ii  cytokinetics inc  phase i  cytokinetics inc  preclinical  cytokinetics inc  pipeline by target  cytokinetics inc  pipeline by route of administration  cytokinetics inc  pipeline by molecule type  cytokinetics inc  pipeline products by mechanism of action  cytokinetics inc  recent pipeline updates  cytokinetics inc  dormant developmental projects list of figures cytokinetics inc  pipeline by top  indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  pipeline by top  target  cytokinetics inc  pipeline by top  route of administration  cytokinetics inc  pipeline by top  molecule type  cytokinetics inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved cytokinetics inc  product pipeline review   infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube cytokinetics inc  product pipeline review   home  pharmaceuticals  global markets direct  cytokinetics inc  product pipeline review   report details cytokinetics inc  product pipeline review   sku gmdmay category pharmaceuticals publisher global markets direct pages  published may skugmdmay categorypharmaceuticals publisherglobal markets direct pages published onmay request discount pay by wireinvoice description table of content list of figures request sample description cytokinetics inc  product pipeline review   summary global markets directs cytokinetics inc  product pipeline review   provides an overview of the cytokinetics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of cytokinetics incs human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the cytokinetics incs pipeline products reasons to buy  evaluate cytokinetics incs strategic position with total access to detailed information on its product pipeline  assess the growth potential of cytokinetics inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the cytokinetics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areas  avoid intellectual property rights related issues newspress release precision medicine how the life science industry can improve outcomes through to achieve successful precision medicine at scale and to be able to offer it as an everyday treatment option researchers in drug rd need to better understand and manage the reams of unstructured datread more regenerative medicine market to hit  billion by  the current regenerative medicine market is worth  billion globally and will hit over  billion by  as impact of trump administrationread more  benefits of microneedlingmicroneedling hundreds of tiny pin pricks going into your skin might sound weird but it could just be the best thing that ever happened to your faceread more table of content table of contents table of contents  list of tables  list of figures  cytokinetics inc snapshot  cytokinetics inc overview  key information  key facts  cytokinetics inc  research and development overview  key therapeutic areas  cytokinetics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  outlicensed products  outlicensed productscombination treatment modalities  cytokinetics inc  pipeline products glance  cytokinetics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  cytokinetics inc  early stage pipeline products  preclinical productscombination treatment modalities  cytokinetics inc  drug profiles  tirasemtiv  product description  mechanism of action  rd progress  ck  product description  mechanism of action  rd progress  ck  product description  mechanism of action  rd progress  ck  product description  mechanism of action  rd progress  small molecule to inhibit myosin for copd asthma and pulmonary arterial hypertension  product description  mechanism of action  rd progress  small molecules for cardiovascular diseases  product description  mechanism of action  rd progress  cytokinetics inc  pipeline analysis  cytokinetics inc  pipeline products by target  cytokinetics inc  pipeline products by route of administration  cytokinetics inc  pipeline products by molecule type  cytokinetics inc  pipeline products by mechanism of action  cytokinetics inc  recent pipeline updates  cytokinetics inc  dormant projects  cytokinetics inc  company statement  cytokinetics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables cytokinetics inc key information  cytokinetics inc key facts  cytokinetics inc  pipeline by indication   cytokinetics inc  pipeline by stage of development   cytokinetics inc  monotherapy products in pipeline   cytokinetics inc  outlicensed products in pipeline   cytokinetics inc  outlicensed products combination treatment modalities   cytokinetics inc  phase ii   cytokinetics inc  phase i   cytokinetics inc  preclinical   cytokinetics inc  pipeline by target   cytokinetics inc  pipeline by route of administration   cytokinetics inc  pipeline by molecule type   cytokinetics inc  pipeline products by mechanism of action   cytokinetics inc  recent pipeline updates   cytokinetics inc  dormant developmental projects  list of figures cytokinetics inc  pipeline by top  indication   cytokinetics inc  pipeline by stage of development   cytokinetics inc  monotherapy products in pipeline   cytokinetics inc  outlicensed products in pipeline   cytokinetics inc  pipeline by top  target   cytokinetics inc  pipeline by top  route of administration   cytokinetics inc  pipeline by top  molecule type   cytokinetics inc  pipeline products by top  mechanism of action   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports lighting product markets in the top  american countries to  lighting product markets in the top  asian countries to  lighting product markets in the top  european countries to  global lighting product market to  lighting product markets in africa to  request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved cytokinetics inc  product pipeline review    reportsnreports market research report welcome guest    registerlogin   contact us   about us      advanced search home ›  pharmaceuticals ›  report detail cytokinetics inc  product pipeline review   published may  no of pages  price  single user license us   corporate user license us     report description table of contents inquire before buying global markets directs cytokinetics inc  product pipeline review   provides an overview of the cytokinetics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of cytokinetics incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the cytokinetics incs pipeline productsreasons to buyevaluate cytokinetics incs strategic position with total access to detailed information on its product pipelineassess the growth potential of cytokinetics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the cytokinetics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areasavoid intellectual property rights related issues cytokinetics inc  product pipeline review   table of contentstable of contents list of tables list of figures cytokinetics inc snapshot cytokinetics inc overview key information key facts cytokinetics inc  research and development overview key therapeutic areas cytokinetics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities cytokinetics inc  pipeline products glance cytokinetics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities cytokinetics inc  early stage pipeline products preclinical productscombination treatment modalities cytokinetics inc  drug profiles tirasemtiv product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress small molecule to inhibit myosin for copd asthma and pulmonary arterial hypertension product description mechanism of action rd progress small molecules for cardiovascular diseases product description mechanism of action rd progress cytokinetics inc  pipeline analysis cytokinetics inc  pipeline products by target cytokinetics inc  pipeline products by route of administration cytokinetics inc  pipeline products by molecule type cytokinetics inc  pipeline products by mechanism of action cytokinetics inc  recent pipeline updates cytokinetics inc  dormant projects cytokinetics inc  company statement cytokinetics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablescytokinetics inc key information cytokinetics inc key facts cytokinetics inc  pipeline by indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  outlicensed products combination treatment modalities  cytokinetics inc  phase ii  cytokinetics inc  phase i  cytokinetics inc  preclinical  cytokinetics inc  pipeline by target  cytokinetics inc  pipeline by route of administration  cytokinetics inc  pipeline by molecule type  cytokinetics inc  pipeline products by mechanism of action  cytokinetics inc  recent pipeline updates  cytokinetics inc  dormant developmental projects list of figurescytokinetics inc  pipeline by top  indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  pipeline by top  target  cytokinetics inc  pipeline by top  route of administration  cytokinetics inc  pipeline by top  molecule type  cytokinetics inc  pipeline products by top  mechanism of action   published by global markets direct product code global markets direct did you find what you arewere looking for  if not read below and browse through other relevant pages for similar market research reports or get in touch with us through the formcontact info in your right navigation panel and well share relevant market report titles for you to explore related reports global onychomycosis tinea unguium drug detailed analysis report  this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value marke  united states vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx fro  united states tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from   philippines vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from   philippines tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from    malaysia vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from   malaysia tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from  to   japan vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  t  japan tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to   india vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  t why reportsnreportscom  market research reports and growing top fortune  organizations trust us for research data  support on call as well as emails your details are safe with us free support for your research requirements report delivery email delivery time upto  hrs  working days upto  hrs max  weekends and public holidays research support  custom research if this business study does not have the data and information analysis you need contact us with your research requirements we explore available market research reports to map your needs and share report titles with you alternatively we can also offer custom research that suits your budget and timelines share your information requirements here connect with us email salesreportsandreportscom call       home category publisher country latest reports markets discounted reports upcoming reports contact us subscription option using our subscription option you get access to market research reports and industry data of consumer goods market as per your needs get the best of consumer goods research reports by utilizing your research budgets in an optimum way more about our subscription option report alerts get email alerts about market research reports from industries and publishers of your interest please enter a valid email id thank you you have successfully subscribed to our report alerts avail upto  discount on below publisher reports technavio azoth analytics   reportsnreports all rights reserved disclamer privacy policy  terms and conditions  our market research blog  sitemap feeds rss  latest reports cytokinetics inc  product pipeline review   sales and support     uk     us infomarketpublisherscom business  finance retail retail consumer goods food  beverage industry chemicals it  technology life sciences medical devices anesthesia  respiratory cardiovascular devices dental diabetes care diagnostic equipment drug delivery endoscopy ear nose  throat ent healthcare equipmentsupplies company reports implants neurology orthopedic ophthalmic surgical equipment wound closure other medical devices biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care pharmaceuticals clinical trial drug stores drugs pharmaceuticals company reports vaccines medical products veterinary services about faq my cart market reports pressreleases events about us terms  conditions customer faq market research reports life sciences pharmaceuticals cytokinetics inc  product pipeline review   date may   pages  price us  license  singleuser license  us  site license  us  enterprisewide license  us  publisher global markets direct report type strategic report delivery email delivery pdf id ccaeen leaflet download pdf leaflet abstracts contents list of tables list of figures cytokinetics inc  product pipeline review  summaryglobal markets direct’s ‘cytokinetics inc  product pipeline review  ’ provides an overview of the cytokinetics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of cytokinetics inc’s human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statement latest news and deals relating to the cytokinetics inc’s pipeline productsreasons to buyevaluate cytokinetics inc’s strategic position with total access to detailed information on its product pipelineassess the growth potential of cytokinetics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the cytokinetics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areasavoid intellectual property rights related issues cytokinetics inc snapshotcytokinetics inc overviewkey informationkey factscytokinetics inc  research and development overviewkey therapeutic areascytokinetics inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapypipeline products  outlicensed productsoutlicensed productscombination treatment modalitiescytokinetics inc  pipeline products glancecytokinetics inc  clinical stage pipeline productsphase ii productscombination treatment modalitiesphase i productscombination treatment modalitiescytokinetics inc  early stage pipeline productspreclinical productscombination treatment modalitiescytokinetics inc  drug profilestirasemtivproduct descriptionmechanism of actionrd progressckproduct descriptionmechanism of actionrd progressckproduct descriptionmechanism of actionrd progressckproduct descriptionmechanism of actionrd progresssmall molecule to inhibit myosin for copd asthma and pulmonary arterial hypertensionproduct descriptionmechanism of actionrd progresssmall molecules for cardiovascular diseasesproduct descriptionmechanism of actionrd progresscytokinetics inc  pipeline analysiscytokinetics inc  pipeline products by targetcytokinetics inc  pipeline products by route of administrationcytokinetics inc  pipeline products by molecule typecytokinetics inc  pipeline products by mechanism of actioncytokinetics inc  recent pipeline updatescytokinetics inc  dormant projectscytokinetics inc  company statementcytokinetics inc  locations and subsidiarieshead officeappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimer list of tablescytokinetics inc key informationcytokinetics inc key factscytokinetics inc  pipeline by indication cytokinetics inc  pipeline by stage of development cytokinetics inc  monotherapy products in pipeline cytokinetics inc  outlicensed products in pipeline cytokinetics inc  outlicensed products combination treatment modalities cytokinetics inc  phase ii cytokinetics inc  phase i cytokinetics inc  preclinical cytokinetics inc  pipeline by target cytokinetics inc  pipeline by route of administration cytokinetics inc  pipeline by molecule type cytokinetics inc  pipeline products by mechanism of action cytokinetics inc  recent pipeline updates cytokinetics inc  dormant developmental projects  list of figurescytokinetics inc  pipeline by top  indication cytokinetics inc  pipeline by stage of development cytokinetics inc  monotherapy products in pipeline cytokinetics inc  outlicensed products in pipeline cytokinetics inc  pipeline by top  target cytokinetics inc  pipeline by top  route of administration cytokinetics inc  pipeline by top  molecule type cytokinetics inc  pipeline products by top  mechanism of action  skip to top more publications sunesis pharmaceuticals inc  product pipeline review   us  apr  ·  pages advantagene inc  product pipeline review   us  feb  ·  pages d western therapeutics institute inc  product pipeline review   us  aug  ·  pages integrated biotherapeutics inc  product pipeline review   us  feb  ·  pages ask your question cytokinetics inc  product pipeline review   company name contact person phonefax email request invoice your enquiry please click on a check box below to confirm you are not a robot market reports all categories biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care medical devices anesthesia  respiratory cardiovascular devices dental devices diabetes care diagnostic equipment drug delivery endoscopy ear nose  throat ent devices healthcare equipmentsupplies company reports neurology orthopedic devices ophthalmic surgical equipment wound closure other medical devices medical products pharmaceuticals clinical trials drug stores drugs pharmaceuticals company reports vaccines veterinary sales and support         infomarketpublisherscom   marketpublisherscom about us our clients our publishers customer faq market reports new publications reports by regions pressreleases terms  conditions privacy policy return policy affiliate program join as publisher follow us market report cytokinetics inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing cytokinetics inc  product pipeline review   may    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs cytokinetics inc  product pipeline review   provides an overview of the cytokinetics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasereport scopethe report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of cytokinetics incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the cytokinetics incs pipeline productsreasons to get this reportevaluate cytokinetics incs strategic position with total access to detailed information on its product pipelineassess the growth potential of cytokinetics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the cytokinetics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contents list of tables list of figures cytokinetics inc snapshot cytokinetics inc overview key information key facts cytokinetics inc  research and development overview key therapeutic areas cytokinetics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities cytokinetics inc  pipeline products glance cytokinetics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities cytokinetics inc  early stage pipeline products preclinical productscombination treatment modalities cytokinetics inc  drug profiles tirasemtiv product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress ck product description mechanism of action rd progress small molecule to inhibit myosin for copd asthma and pulmonary arterial hypertension product description mechanism of action rd progress small molecules for cardiovascular diseases product description mechanism of action rd progress cytokinetics inc  pipeline analysis cytokinetics inc  pipeline products by target cytokinetics inc  pipeline products by route of administration cytokinetics inc  pipeline products by molecule type cytokinetics inc  pipeline products by mechanism of action cytokinetics inc  recent pipeline updates cytokinetics inc  dormant projects cytokinetics inc  company statement cytokinetics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablescytokinetics inc key information cytokinetics inc key facts cytokinetics inc  pipeline by indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  outlicensed products combination treatment modalities  cytokinetics inc  phase ii  cytokinetics inc  phase i  cytokinetics inc  preclinical  cytokinetics inc  pipeline by target  cytokinetics inc  pipeline by route of administration  cytokinetics inc  pipeline by molecule type  cytokinetics inc  pipeline products by mechanism of action  cytokinetics inc  recent pipeline updates  cytokinetics inc  dormant developmental projects list of figurescytokinetics inc  pipeline by top  indication  cytokinetics inc  pipeline by stage of development  cytokinetics inc  monotherapy products in pipeline  cytokinetics inc  outlicensed products in pipeline  cytokinetics inc  pipeline by top  target  cytokinetics inc  pipeline by top  route of administration  cytokinetics inc  pipeline by top  molecule type  cytokinetics inc  pipeline products by top  mechanism of action   companies mentioned in this reportcytokinetics inc this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc cytokinetics inc  product pipeline review    rnr market research advanced search     salesrnrmarketresearchcom search market research reports ﻿ market research assistance salesrnrmarketresearchcom on the web related markets biotechnologybiomaterialsbiomarkersstem celldrug discoveryindustrial biotechnologywound careenzymemicroarraybiopharmaceuticalcell culture related market reportscytokinetics incorporated  product pipeline review  opportunityanalyzer amyotrophic lateral sclerosis als  opportunity analysis and forecasts to  home  life sciences  pharmaceuticals  report detail cytokinetics inc  product pipeline review   publisher name  global markets direct date may no of pages  price single user license us  corporate user license us  report descriptiontable of contentnews  blogother reportsour offerings global markets directs cytokinetics inc  product pipeline review   provides an overview of the cytokinetics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of cytokinetics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of cytokinetics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of cytokinetics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the cytokinetics incs pipeline products reasons to buy evaluate cytokinetics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of cytokinetics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the cytokinetics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of cytokinetics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of cytokinetics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of cytokinetics inc and identify potential opportunities in those areas avoid intellectual property rights related issues cytokinetics inc  product pipeline review   table of contents table of contents  list of tables  list of figures  cytokinetics inc snapshot  cytokinetics inc overview  key information  key facts  cytokinetics inc  research and development overview  key therapeutic areas  cytokinetics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  outlicensed products  outlicensed productscombination treatment modalities  cytokinetics inc  pipeline products glance  cytokinetics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  cytokinetics inc  early stage pipeline products  preclinical productscombination treatment modalities  cytokinetics inc  drug profiles  tirasemtiv  product description  mechanism of action  rd progress  ck  product description  mechanism of action  rd progress  ck  product description  mechanism of action  rd progress  ck  product description  mechanism of action  rd progress  small molecule to inhibit myosin for copd asthma and pulmonary arterial hypertension  product description  mechanism of action  rd progress  small molecules for cardiovascular diseases  product description  mechanism of action  rd progress  cytokinetics inc  pipeline analysis  cytokinetics inc  pipeline products by target  cytokinetics inc  pipeline products by route of administration  cytokinetics inc  pipeline products by molecule type  cytokinetics inc  pipeline products by mechanism of action  cytokinetics inc  recent pipeline updates  cytokinetics inc  dormant projects  cytokinetics inc  company statement  cytokinetics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables cytokinetics inc key information  cytokinetics inc key facts  cytokinetics inc  pipeline by indication   cytokinetics inc  pipeline by stage of development   cytokinetics inc  monotherapy products in pipeline   cytokinetics inc  outlicensed products in pipeline   cytokinetics inc  outlicensed products combination treatment modalities   cytokinetics inc  phase ii   cytokinetics inc  phase i   cytokinetics inc  preclinical   cytokinetics inc  pipeline by target   cytokinetics inc  pipeline by route of administration   cytokinetics inc  pipeline by molecule type   cytokinetics inc  pipeline products by mechanism of action   cytokinetics inc  recent pipeline updates   cytokinetics inc  dormant developmental projects  list of figures cytokinetics inc  pipeline by top  indication   cytokinetics inc  pipeline by stage of development   cytokinetics inc  monotherapy products in pipeline   cytokinetics inc  outlicensed products in pipeline   cytokinetics inc  pipeline by top  target   cytokinetics inc  pipeline by top  route of administration   cytokinetics inc  pipeline by top  molecule type   cytokinetics inc  pipeline products by top  mechanism of action   highspeed data transmission and high volume needs propel fiber optic connectors market fiber optic connectors are a substantial fragment of the global telecommunication industry optical fibers are joined using fiber optic connectors which allow the light conduction between two consecutive optical fibers an additional im…extensive use of digital technologies for diagnostic applications to boost global optical imaging market the global optical imaging system market is predicted to reach us  billion by  it is expected to grow at a stable rate and will post a cagr of more than  in the coming years the growing market infiltration of digital …foremost trends in global pet care market the global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments it is estimated that the global pet care market will grow at a cagr o…china to review its food security laws china has arisen as the globe’s firmest developing economy in addition china brags about the biggest population pool in the world in recent times the one child policy in the republic was terminated this is anticipated to upsur…improving standards of living to boost global consumer durables market consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time profits in the consumer durables sector were most profoundly…  philippines vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from  to  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac   united states vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from  to  in united states market the top players include coopersurgical medgyn personal medical corp integra lifesciences   top  vaginal pessary manufacturers in north america europe asiapacific south america middle east and africa published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the global vaginal pessary market size will be xx million usd in  from the xx million usd in  with a cagr compound annual growth rate xx from  to  this report studies vaginal pessary in global market especially in north america europe asiapacific south america middle east and africa focuses on the top  vaginal pessary players in each reg  china vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in china from the xx million usd in  with a cagr compound annual growth rate xx from  to  in china market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  global top countries vaginal pessary market report published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the global vaginal pessary market size will be xx million usd in  from the xx million usd in  with a cagr compound annual growth rate xx from  to  this report studies vaginal pessary in global market especially in united states canada mexico germany france uk italy russia china japan india korea southeast asia australia brazil mi  india vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  to  in india market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  japan vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to  in japan market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  malaysia vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from  to  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac med emea europe middle east and africa paramenthanediol pmd market report  published jul        price us  onwards        pages  in this report the emea paramenthanediolpmd market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split emea into europe the middle east and africa with sales k mt revenue million usd market share and growth rate of paramenthanediolpmd for these regions from  to  forecast  europe germany france uk russia italy services value for money we believe in optimum utilization of available budget and resources while servicing our clients your market research requirements we keep the same approach in focus to help you get the best value for your s ever growing inventory ranging from the smallest feasible  required data datasheets data facts swot analysis company profiles etc to full research reports that help you make decisions our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than  niche sectors one stop solution need a custom research report on medical devices market require all available business intelligence on d printing industry exploring fb sector of a particular countryregion rnrmarketresearchcom is your onestopsolution to all market intelligence needs we not only offer custom research and consulting services we also bundle reports to meet your needs and help you fetch the data analysis you require for your business dedicated client engagement not limited to only finding relevant reports for you our client engagement team dedicates its efforts to understand your business need and accordingly maps available research data to help you move forward call your client engagement executive any time of your day and get your questions answered in order to make the correct business decision saving time and efforts simply share your research requirement details with us and let us do all the hard work to find required intelligence for you when you add up our one stop solution and dedicated client engagement services mentioned above you obviously know the time and effort saving you do by working with us payment flexibility working with fortune  organizations we understand the importance of being flexible for payments share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done postpurchase research support have questions after reading a report  datasheet bought through us not sure about the methodology used for data available in the research talk to us  share your questions with us and if required we will connect you with the analystsauthors of the reports and ensure you get satisfactory answers for the same need more data  analysis  reports on the topic of your researchproject the rnrmarketresearchcom team is here for you x to support you with your postpurchase requirements subscription offers  packages get in touch with us for more details  salesrnrmarketresearchcom       ad hoc pay  as  you  go  bucket subscriptions fixed cost for of reports customize  personalize as per your needs avail upto  discount on below publisher reports azoth analytics technavio pharmaceuticals market research reports on market size and competitive analysis advanced search     salesrnrmarketresearchcom search market research reports market research assistance salesrnrmarketresearchcomon the web refine resultby datelast monthlast  monthslast  monthslast yearlast  years by price  home     life sciences    pharmaceuticals pharmaceuticals market research reports the global pharmaceutical market has persistently experienced significant growth due to the everincreasing demand for novel and more effective drugs the reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth newer and more complex disease conditions ageing population and the increased prevalence of chronic and infectious diseases some of which still remain incurable and fatal such numerous unmet needs and high demand rates have triggered the boost in rd investments by key industry sectors greatly driving the growth of this industry the pharmaceutical market valued as a multibillion dollar market is undoubtedly the largest revenue generator for the life sciences industry the pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications the largest segment the market for cardiovascular drugs records huge sales every year the rising world population rapview more the global pharmaceutical market has persistently experienced significant growth due to the everincreasing demand for novel and more effective drugs the reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth newer and more complex disease conditions ageing population and the increased prevalence of chronic and infectious diseases some of which still remain incurable and fatal such numerous unmet needs and high demand rates have triggered the boost in rd investments by key industry sectors greatly driving the growth of this industry the pharmaceutical market valued as a multibillion dollar market is undoubtedly the largest revenue generator for the life sciences industry the pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications the largest segment the market for cardiovascular drugs records huge sales every year the rising world population rapid ageing of the same and an increased prevalence of diseases are the major factors driving growth of this industry the recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry for the possibility of newer advanced and more sophisticated therapies and drugs developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals regenerative medicine stem cells etc these new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders technological growth in such interdisciplinary fields has opened up new arenas in drug discovery drug delivery and life sciences researchview less therapeuticsdiseases  treatmentclinical trialdietary supplementsbiopharmaceuticalspharmaceutical packagingpain managementpandemic vaccinebiosimilarpharmaceutical distributionover the counter otc druganesthesia drugscancer vaccinepharmaceutical technologyradiopharmaceuticalprescription drugspharmaceutical detailingclinical nutrition pharmaceuticals market research reports titlepublishedprice global onychomycosis tinea unguium drug detailed analysis report by qyresearch group oduct type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in onychomycosis tinea unguium drug industry this report focus global market it covers djul  united states vaginal pessary market report status and outlookby lp information inc  in united states market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smijul  united states tuberculin market report status and outlookby lp information inc r  in united states market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  philippines vaginal pessary market report status and outlookby lp information inc in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medjul  philippines tuberculin market report status and outlookby lp information inc  in malaysia market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  malaysia vaginal pessary market report status and outlookby lp information inc r  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medicajul  malaysia tuberculin market report status and outlookby lp information inc in malaysia market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  japan vaginal pessary market report status and outlookby lp information inc  in japan market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medicaljul  japan tuberculin market report status and outlookby lp information inc trongin japan market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbg jul  india vaginal pessary market report status and outlookby lp information inc  in india market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medicaljul                 next » avail upto  discount on below publisher reports azoth analytics technavio cytokinetics  muscle biology therapies  home our focus we’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions overview how muscles work amyotrophic lateral sclerosis heart failure spinal muscular atrophy pipeline we’re advancing muscle biologydriven treatments for diseases characterized by compromised muscle function muscle weakness and fatigue overview omecamtiv mecarbil tirasemtiv ck publications scientific events clinical trials we have conducted more than  clinical trials as we strive to bring important new medicines to patients with diseases like als heart failure and sma overview helpful resources expanded accesscompassionate use company cytokinetics is a latestage biopharmaceutical company focused on discovering developing and commercializing firstinclass muscle activators overview leadership team careers our culture grant programs contact us investors  media cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance investor overview stock information press releases in the news calendar presentations sec filings proxy information analyst coverage investor faq irmedia contacts corporate governance information request email alerts empoweringmuscleempoweringlives as a leader in muscle biology research we are dedicated to our mission of improving the lives of people confronting devastating diseases of impaired muscle function learn more breaking news news als people fighting amyotrophic lateral sclerosis have few treatment options we are dedicated to changing the progression of this fatal disease learn more heart failure heart failure death and disability rates continue to rise despite current treatment options with amgen we are developing a novel therapy that may improve cardiac performance in people with heart failure learn more sma people suffering from spinal muscular atrophy experience devastating loss of muscle function with astellas we are working on a treatment that may enhance skeletal muscle performance in these and other patients learn more cytokinetics inc cytko company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile cytokinetics inc cytko related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse cytko on nasdaq usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description cytokinetics incorporated incorporated on august   is a latestage biopharmaceutical company the company is focused on discovering developing and commercializing firstinclass muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised andor declining it is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions the company is developing small molecule drug candidates which are specifically engineered to increase muscle function and contractility the companys drug candidates which are in clinical development include tirasemtiv ck and omecamtiv mecarbil tirasemtivthe companys lead drug candidate from its skeletal muscle contractility program tirasemtiv is a skeletal muscle troponin activator the company is developing tirasemtiv drug candidate for the treatment of amyotrophic lateral sclerosis als it has conducted a phase ii clinical trials program for tirasemtiv including a phase iib clinical trial in patients with als known as blinded evaluation of neuromuscular effects and functional improvement with tirasemtiv in als benefitals the company has also started ventilatory investigation of tirasemtiv and assessment of longitudinal indices after treatment for a year in als vitalityals a multinational randomized doubleblind placebocontrolled trial which is designed to assess tirasemtiv effects versus placebo on measures of respiratory function and muscle strength in people with als tirasemtiv has been granted orphan drug designation and fast track status by the united states food and drug administration and orphan medicinal product designation by the european medicines agency for the potential treatment of alsckck is a skeletal muscle troponin activator the company is developing ck for the potential treatment of spinal muscular atrophy sma chronic obstructive pulmonary disease copd and als the company has started enrollment of the phase ii clinical trial of ck in patients with sma which is designed to assess effects of ck on multiple measures of muscle function in both ambulatory and nonambulatory patients with sma it has also started a phase ii clinical trial of ck in patients with copd ck is also being evaluated for potential use in other indications associated with muscle weaknessomecamtiv mecarbilthe companys lead drug candidate from its cardiac muscle contractility program omecamtiv mecarbil is a cardiac muscle myosin activator its omecamtiv mecarbil is being investigated as a potential treatment for heart failure the company has conducted chronic oral study of myosin activation to increase contractility in heart failure cosmichf a phase ii doubleblind randomized placebocontrolled multicenter clinical trial which is designed to assess the pharmacokinetics and tolerability of omecamtiv mecarbil dosed orally in patients with heart failure and left ventricular systolic dysfunction as well as its effects on echocardiographic measures of cardiac function the company has conducted a phase iib clinical trial known as acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure atomicahf for intravenous formulation of omecamtiv mecarbil atomicahf evaluates the safety and efficacy of omecamtiv mecarbil in patients with left ventricular systolic dysfunction who are hospitalized with acute heart failure » full overview of cytko company address cytokinetics inc  e grand avesouth san francisco   ca    p f  company web links home page officers  directors name compensation leonard patrick gage  robert blum  ching jaw  sharon barbari  fady malik  » more officers  directors cytokinetics inc news briefcytokinetics reports baseline data from first cohort of phase  clinical trial of ck in patients with sma jul   briefcytokinetics starts phase b clinical trial of ck in elderly subjects jun   briefcytokinetics announces orphan drug designation for ck for treatment of spinal muscular atrophy may   briefcytokinetics announces results from dose escalation phase of cosmichf may   briefcytokinetics q loss per share  apr   » more cytko news related topics stocksstock screenerhealthcarebiotechnology  medical research cytokinetics  muscle biology therapies  home our focus we’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions overview how muscles work amyotrophic lateral sclerosis heart failure spinal muscular atrophy pipeline we’re advancing muscle biologydriven treatments for diseases characterized by compromised muscle function muscle weakness and fatigue overview omecamtiv mecarbil tirasemtiv ck publications scientific events clinical trials we have conducted more than  clinical trials as we strive to bring important new medicines to patients with diseases like als heart failure and sma overview helpful resources expanded accesscompassionate use company cytokinetics is a latestage biopharmaceutical company focused on discovering developing and commercializing firstinclass muscle activators overview leadership team careers our culture grant programs contact us investors  media cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance investor overview stock information press releases in the news calendar presentations sec filings proxy information analyst coverage investor faq irmedia contacts corporate governance information request email alerts empoweringmuscleempoweringlives as a leader in muscle biology research we are dedicated to our mission of improving the lives of people confronting devastating diseases of impaired muscle function learn more breaking news news als people fighting amyotrophic lateral sclerosis have few treatment options we are dedicated to changing the progression of this fatal disease learn more heart failure heart failure death and disability rates continue to rise despite current treatment options with amgen we are developing a novel therapy that may improve cardiac performance in people with heart failure learn more sma people suffering from spinal muscular atrophy experience devastating loss of muscle function with astellas we are working on a treatment that may enhance skeletal muscle performance in these and other patients learn more cytokinetics  east of    tips foursquarelog insign upnearbyget inspiredtop pickstrendingfoodcoffeenightlifefunshoppingcytokineticsofficeeast of  south san franciscosavesharetipscytokineticsno tips and reviewslog in to leave a tip herepostno tips yetwrite a short note about what you liked what to order or other helpful advice for visitors photorelated searchescytokinetics south san francisco  cytokinetics south san francisco photos  cytokinetics south san francisco location  cytokinetics south san francisco address  cytokinetics south san francisco  cytokinetics south san francisco  cytokinetics east of  south san franciscoaboutblogbusinessescitiesdevelopershelpjobscookies updatedprivacy updatedtermsenglishenglish français deutsch bahasa indonesia italiano 語 한국어 português русский español ภาษาไทย türkçe citiesatlantaaustinbostonchicagodallasdenverhoustonlas vegaslos angelesnew yorkphiladelphiaportlandsan diegosan franciscoseattlewashington dccountriesbelgiumbrazilcanadachilefinlandfrancegermanygreat britainhungaryindonesiajapanmexiconetherlandsphilippinesrussiasingaporespainthailandturkeymore great places in south san franciscoabcdefghijklmnopqrstuvwxyzfoursquare    lovingly made in nyc  sfcytokinetics e grand ave littlefieldsouth san francisco ca united statesget directions none listed see when people check inpeople tend to check in during these timestodaynonemon am– pm pm– pmtue am– pm pm– pmwed–thu am– pm pm– pmfri am– pmsatnonesee moreunited states » san mateo county » south san francisco » east of professional  other places » officeis this your business claim it nowmake sure your information is up to date plus use our free tools to find new customersyou must enable javascript to use foursquarecomwe use the latest and greatest technology available to provide the best possible web experienceplease enable javascript in your browser settings to continuedownload foursquare for your smart phone and start exploring the world around you bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one